[ET Net News Agency, 1 September 2022] Shares of BIOCYTOGEN-B (02315) opened at HK$26.3
in its first trading day, or 4.28% higher than its offer price of HK$25.22.
The stock's IPO was 4.93 times oversubscribed, with a board-lot winning rate of 50%.
(ed)